ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,427.61
      0.55%
      Dow Jones
      42,208.22
      0.20%
      Brent Oil
      74.56
      1.12%
      Bitcoin
      64,440.49
      1.76%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Athersys Inc (ATHX) Quote

      Athersys Inc

      Athersys Inc (ATHX)

      NASDAQ
      0.1018
      0.00
      (0.00%)
      At close: September 24 4:00PM
      Delayed by 15 minutes
      0.1018
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.1018
      Bid
      0.101
      Ask
      0.104
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      1.831M
      Previous Close
      0.1018
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,986,000
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -4.03
      Revenue
      5.33M
      Net Profit
      -72.53M

      About Athersys Inc

      Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are foc... Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.athersys.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      ATHX Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      10 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      10 hours ago

      Form 8-K - Current report

      January 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 22 2023
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 21 2023
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 16 2023
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 18 2023
      Edgar (US Regulatory)

      Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

      Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces it has...

      October 16 2023
      Business Wire

      Form 8-K - Current report

      October 12 2023
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 11 2023
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ELYMEliem Therapeutics Inc
      $ 9.82
      (49.70%)
      		1.25M
      MSGMMotorsport Games Inc
      $ 1.46
      (32.73%)
      		2.68M
      XHGXChange TED Inc
      $ 1.49
      (24.17%)
      		3.11M
      FEAM5E Advanced Materials Inc
      $ 0.5045
      (23.53%)
      		2.08k
      VSMEVS Media Holdings Ltd
      $ 1.48
      (20.33%)
      		600.65k
      SFIXStitch Fix Inc
      $ 2.85
      (-24.00%)
      		1.28M
      ATXSAstria Therapeutics Inc
      $ 10.54
      (-15.68%)
      		51.6k
      BNZIBanzai International Inc
      $ 7.36
      (-10.68%)
      		697.72k
      TRNRInteractive Strength Inc
      $ 0.235
      (-10.31%)
      		1.37M
      VEVVicinity Motor Corporation
      $ 0.1371
      (-8.90%)
      		430.58k
      INTCIntel Corporation
      $ 22.8001
      (-0.04%)
      		17.45M
      NVDANVIDIA Corporation
      $ 121.55
      (0.56%)
      		15.17M
      JGLOJP Morgan Global Select Equity ETF
      $ 62.28
      (0.00%)
      		13.85M
      ELABElevai Labs Inc
      $ 0.1238
      (20.19%)
      		12.68M
      LIPOLipella Pharmaceuticals Inc
      $ 0.50
      (10.35%)
      		6.47M

      Discussion

      View Full Feed
      Kool Aid Man Kool Aid Man 29 seconds ago
      Prominent (adjective): projecting from something; protuberant.

      Protuberant (adjective): protruding; bulging.

      Origin (Latin): Pro= forward/ out + Tuber= bump (i.e. potato, turnip, yam or other dirt dwelling growth)
      SPZI
      fink fink 33 seconds ago
      Yulp. I've help many for years.

      It just takes one.
      It's why I used to hold a good 3 dozen shells mom down to a handfull now. Maybe it will change in Nov. if not, I'm out 100% and buying a chunk of gold.
      ECPL
      hopester hopester 57 seconds ago
      " Sales outlook improving"? Expenses far beyond anything the improvement in sales will overcome.
      Realize losses will continue through 2029 say the well thought out professionals.
      Nothing wrong with hoping it gets to $1. or $1.50 if that's your goal. But for now, its only HOPE and no c
      FCEL
      janice shell janice shell 1 minute ago
      Maybe here?

      https://www.nbc.com/from-russia-with-lev

      Or here?

      https://www.imdb.com/title/tt33070481/
      gfp927z gfp927z 1 minute ago
      QT pace - >>> Fed announces reduction in balance sheet runoff pace


      Reuters

      by Michael S. Derby

      May 1, 2024


      https://www.reuters.com/markets/us/fed-announces-reduction-balance-sheet-runoff-pace-2024-05-01/

      RMS555 RMS555 1 minute ago
      Maxed Authorized Shares, Reverse Split Filed, No Revenue in over 1.5 years. RED FLAGS EVERYWHERE!

      .
      INCC
      StevenRisk StevenRisk 1 minute ago
      Weird as though Dye and his minion make it sound like their is absolutely nothing wrong here. Yet the price share languishes between .01 to .20
      Any thoughts? Honestly I really dont know what to think.
      SHWZ
      trading.jeff trading.jeff 1 minute ago
      I saw that, also. On another site, I saw someone refer to the "rude of all evil." Gotta wonder about some people; spend too much time under a stone.
      APRU
      WALLnut WALLnut 2 minutes ago
      Dude, you're spot on with your Radiogel time frame but we are dealing with FDA here. If after Sprint Discussions meetings are done and FDA gives green light to resubmit....then I'll be extremely giddy and posting here every 5 seconds (LOL) because this "should" be the last hurdle.

      RDGL
      gfp927z gfp927z 3 minutes ago
      QT pace - >>> Fed announces reduction in balance sheet runoff pace


      Reuters

      by Michael S. Derby

      May 1, 2024


      https://www.reuters.com/markets/us/fed-announces-reduction-balance-sheet-runoff-pace-2024-05-01/

      OMOLIVES OMOLIVES 3 minutes ago
      Oh yeah ...I know. There was just another stopgap funding bill...lol. Like that shouldn't remind me. :)
      mick mick 3 minutes ago
      GOOD LINK 02

      https://www.youtube.com/channel/UCLesNX-Yc1bb7mSMefESgSw
      fink fink 4 minutes ago
      09/24/2024
      BRISTOL, CT / ACCESSWIRE / September 24, 2024 / Recruiter.com Group, Inc. (NASDAQ:RCRT) (the "Company") today announced the completion of the sale of its website and certain associated intellectual property, www.recruiter.com, to Job Mobz, Inc. The sale is part of the Company's ong
      AESO
      Denzel-72 Denzel-72 4 minutes ago
      Rounds off to your yearly subscription to Ihub …I see you get your money’s worth
      KEGS
      williamjr williamjr 4 minutes ago
      Hi All : PLUG got the hiring sign out on the website for St. Gabriel, LA
      PLUG
      vlispxpert vlispxpert 8 minutes ago
      added CLSK too, bitcoin going nuts
      CLSK
      KRISGO KRISGO 8 minutes ago
      Here’s what I understood so far regarding Stephen Johnson's treatment or any other GoFundMe links for glioblastoma in the UK (especially London):

      1. Patients typically start by contacting King's College for medical advice, with Dr. Ashkan being the primary contact to determine the mos
      NWBO
      kund kund 8 minutes ago
      There won't be any news because of "EMBARGO", Clown's favorite word. There is a reason why he like to attends these conference with same old shitty data.
      AVXL
      vlispxpert vlispxpert 9 minutes ago
      Added MARA:

      JUST IN: World's largest custodian bank BNY Mellon is close to rolling out custody services for spot #Bitcoin ETF funds — Bloomberg
      Macquarie Initiates Coverage On MARA Holdings with Outperform Rating, Announces Price Target of $22
      dstock07734 dstock07734 10 minutes ago
      Researchers share new cancer treatments to offer hope for patients | Morning in America

      https://www.newsnationnow.com/morninginamerica/researchers-share-new-cancer-treatments-to-offer-hope-for-patients-morning-in-america/
      NWBO
      1hot toddy 1hot toddy 10 minutes ago
      Refinitiv 2.60 buy rating from Schwab. Hold on for ride upppp. $$$$
      LODE
      RedShoulder RedShoulder 11 minutes ago
      Hi Tom; I believe the SP going forward will be news driven.
      AVXL
      Make It Jake Make It Jake 11 minutes ago
      VWave and AIM-CASH: Checking the high values (3)

      This part will go into detail about the high VWave values.

      Following a valuable comment from a certain Monsieur V., I decided to update the tests to filter out several one-week-long whipsaw excursions from the mid-range
      Lime Time Lime Time 11 minutes ago
      Trying to get it back current it seems.
      HIPH

      Your Recent History

      NASDAQ
      ATHX
      Athersys
      Delayed Upgrade Clock